← ANALYSTS · TIPRANKS
David Hoang · Deutsche Bank
Hits
67%
56 of 83 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+34.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
14
Buy / hold / sell: 8 / 5 / 1
Upside of the analyst’s targets
+41.9%
Average over 14 current targets, to the last price
The market’s answer to the ratings
+5.2%
Day-0 move against SPY in the rating’s direction, average over 13 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 1on TipRanks 09:08 | HRMYIWMHarmony Biosciences Holdings · $2.2B | Reiterated | Hold | $39.00 → $42.00+7.7% | +10.7% | +0.6%next day −0.6% · 5 days −1.2% | ↗ |
| Sep 29on TipRanks 09:11 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $280 → $267−4.6% | +69.9% | −3.8%next day −0.7% · 5 days −8.3% | ↗ |
| Sep 25on TipRanks 08:35 | ACADIWMACADIA Pharmaceuticals · $3.4B | Reiterated | Buy | $38.00 → $31.00−18.4% | +62.1% | −7.3%next day 0.0% · 5 days −3.3% | ↗ |
| Sep 18on TipRanks 05:35 | XENEIWMXenon · $3.3B | Downgrade | Hold | $90.00 → $46.00−48.9% | +37.4% | −30.8%next day −3.5% · 5 days −8.3% | ↗ |
| Aug 27on TipRanks Aug 28 04:40 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Initiated | Hold | $120 | +39.3% | −0.1%next day −4.5% · 5 days −7.1% | ↗ |
| Aug 26on TipRanks 04:45 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $287 → $300+4.5% | +42.7% | −4.2%next day +0.1% · 5 days −1.4% | ↗ |
| Aug 26on TipRanks 04:45 | SYREIWMSpyre Therapeutics · $7.3B | Reiterated | Buy | $135 → $127−5.9% | +58.9% | −12.8%next day −0.6% · 5 days −6.9% | ↗ |
| Aug 13on TipRanks 03:15 | NBIXNeurocrine · $13.9B | Assigned | Hold | $190 → $165−13.2% | +21.6% | −4.3%next day +1.5% · 5 days +3.4% | ↗ |
| Aug 5on TipRanks 09:25 | HRMYIWMHarmony Biosciences Holdings · $2.2B | Assigned | Hold | $36.00 → $39.00+8.3% | +2.8% | −1.2%next day +1.5% · 5 days +3.6% | ↗ |
| Jul 29on TipRanks Jul 30 05:17 | KYMRIWMKymera Therapeutics · $9.0B | Initiated | Hold | $120 | +14.5% | +0.7%next day 0.0% · 5 days −5.3% | ↗ |
| Jul 16on TipRanks 04:30 | DNLIIWMDenali Therapeutics · $2.9B | Assigned | Buy | $31.00 → $35.00+12.9% | +98.8% | −0.7%next day +3.5% · 5 days +4.7% | ↗ |
| Jun 26on TipRanks 08:40 | BHVNIWMBiohaven Ltd. · $1.7B | Assigned | Buy | $15.00 → $20.00+33.3% | +85.5% | +3.9%next day −7.2% · 5 days −1.7% | ↗ |
| Jun 2on TipRanks 04:35 | PRAXIWMPraxis Precision Medicines · $6.9B | Reiterated | Buy | $420 → $374−11.0% | +54.7% | −23.1%next day +8.8% · 5 days 0.0% | ↗ |
| Mar 26on TipRanks 08:45 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Sell | $12.00 → $14.00+16.7% | −18.1% | −7.0%next day −6.2% · 5 days +5.5% | ↗ |
| Nov 13on TipRanks 04:15 | ALKSIWMAlkermes · $6.7B | Reiterated | Buy | $55.00 → $45.00−18.2% | +9.2% | +0.4%next day −6.3% · 5 days −6.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗